(1H-Indol-2-yl)(4-(2-(4-methoxyphenoxy)ethyl)piperazin-1-yl)methanone

ID: ALA4476784

Cas Number: 1386162-69-1

PubChem CID: 27842480

Product Number: M412605, Order Now?

Max Phase: Preclinical

Molecular Formula: C22H25N3O3

Molecular Weight: 379.46

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1

Standard InChI:  InChI=1S/C22H25N3O3/c1-27-18-6-8-19(9-7-18)28-15-14-24-10-12-25(13-11-24)22(26)21-16-17-4-2-3-5-20(17)23-21/h2-9,16,23H,10-15H2,1H3

Standard InChI Key:  HAZPAMUWUHDPDA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   33.9155   -5.4641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9131   -4.6428    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6237   -4.2280    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.2000   -4.2322    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.3387   -4.6424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0472   -4.2311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0490   -3.4094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.3361   -3.0008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.6214   -3.4096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7570   -3.0014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4685   -3.4105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1807   -3.0025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.8922   -3.4117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8875   -4.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5982   -4.6447    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3113   -4.2325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.3093   -3.4069    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.5981   -3.0015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0233   -4.6448    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.0238   -5.4661    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2534   -5.9448    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.5838   -5.9409    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3296   -6.7229    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5121   -6.7236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1078   -7.4313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.5157   -8.1388    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3362   -8.1342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7410   -7.4260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  3  5  1  0
  3  9  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  7 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
 16 19  1  0
 19 20  1  0
  1 21  1  0
 21 24  1  0
 23 22  1  0
 22  1  2  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4476784

   ML417

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 379.46

Molecular Weight (Monoisotopic): 379.1896

AlogP: 3.01

#Rotatable Bonds: 6

Polar Surface Area: 57.80

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 6.53

CX LogP: 2.62

CX LogD: 2.57

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.72

Np Likeness Score: -1.29

References

1. Moritz AE, Free RB, Weiner WS, Akano EO, Gandhi D, Abramyan A, Keck TM, Ferrer M, Hu X, Southall N, Steiner J, Aubé J, Shi L, Frankowski KJ, Sibley DR..  (2020)  Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist.,  63  (10): [PMID:32342685] [10.1021/acs.jmedchem.0c00424]

Source

Source(1):

• Scientific Literature